Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05875805 · ClinicalTrials.gov registry record · NA

A Telehealth Advance Care Planning Intervention

A NA study of Acute Myeloid Leukemia and Myelodysplastic Syndromes, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
207
Enrollment target
1
Study location

NCT05875805 is a NA study of Acute Myeloid Leukemia and Myelodysplastic Syndromes that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 207 participants, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (80% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05875805, a NA study of Acute Myeloid Leukemia and Myelodysplastic Syndromes, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
207 participants
Enrollment target
1
Study location

Study Summary

The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.

Interventions

  • BEHAVIORAL Telehealth Serious Illness Care Program
  • OTHER Education Control

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2024-05-20
Est. Completion 2027-12-31
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT05875805

The ClinicalTrials.gov registry entry for NCT05875805 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (80% higher). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 2 interventions - of which Telehealth Serious Illness Care Program is the first listed.

NCT05875805 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05875805 about?

NCT05875805 is a clinical study titled "A Telehealth Advance Care Planning Intervention". The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare pro...

What is the current status of trial NCT05875805?

This trial is currently recruiting. It is a NA study. The enrollment target is 207 participants. The study started on 2024-05-20. Estimated completion is 2027-12-31.

What conditions does trial NCT05875805 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelofibrosis, Myelodysplastic/Myeloproliferative Neoplasm, Myeloid Malignancy.

What interventions are being tested in trial NCT05875805?

The interventions under investigation include: Telehealth Serious Illness Care Program (BEHAVIORAL), Education Control (OTHER).

Who is sponsoring clinical trial NCT05875805?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05875805 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.